CN1763201A - Chlamys farreri G type lysozyme gene and proteins encoded and cloning process thereof - Google Patents

Chlamys farreri G type lysozyme gene and proteins encoded and cloning process thereof Download PDF

Info

Publication number
CN1763201A
CN1763201A CN 200410050651 CN200410050651A CN1763201A CN 1763201 A CN1763201 A CN 1763201A CN 200410050651 CN200410050651 CN 200410050651 CN 200410050651 A CN200410050651 A CN 200410050651A CN 1763201 A CN1763201 A CN 1763201A
Authority
CN
China
Prior art keywords
chlamys farreri
lysozyme gene
type lysozyme
gene
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200410050651
Other languages
Chinese (zh)
Other versions
CN100344762C (en
Inventor
宋林生
邹慧斌
胥炜
相建海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Oceanology of CAS
Original Assignee
Institute of Oceanology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Oceanology of CAS filed Critical Institute of Oceanology of CAS
Priority to CNB2004100506518A priority Critical patent/CN100344762C/en
Publication of CN1763201A publication Critical patent/CN1763201A/en
Application granted granted Critical
Publication of CN100344762C publication Critical patent/CN100344762C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to G type N,O-Diacetylmuramidase, particularly chlamys farreri G type lysozyme gene and proteins encoded and cloning process thereof; Chlamys farreri G type lysozyme gene has the base sequence shown in the SEQ ID NO.1, and its proteins encoded has the aminoacid sequence shown in the SEQ ID NO.2.The chlamys farreri G type lysozyme gene that the present invention is cloned into has polyadenylic acid tailing signal and polyadenylic acid tail, this gene has critical function aspect the scallop immune defense, can be used for the recombinant expressed and transgenosis of N,O-Diacetylmuramidase, and for the disease control of chlamys farreri, gene assist-breeding and further be developed as pharmaceutical prod and lay the foundation.

Description

Chlamys farreri G type lysozyme gene and proteins encoded and cloning process thereof
Technical field
The present invention relates to G type N,O-Diacetylmuramidase, particularly chlamys farreri G type lysozyme gene (cDNA complete sequence and aminoacid sequence) reaches the cloning process that clones the chlamys farreri N,O-Diacetylmuramidase from chlamys farreri cDNA.
Background technology
N,O-Diacetylmuramidase is found (Proc.R.Soc.Lond.B.Biol.Sci.1922) by Fu Laiming in nineteen twenty-two.This enzyme full name is 1; 4-β-N-N,O-Diacetylmuramidase; claim mucopeptide N-ethanoyl muramyl lytic enzyme again; β-1 in the energy hydrolytic bacteria cell walls between N-acetylglucosamine and the-acetylmuramic acid, the 4-glycosidic link destroys the peptidoglycan support; the cell spalling is opened under the effect that internal penetration is pressed; cause the bacterium cracking, so claim muramidase again, i.e. N-acetyl murein glucosides glycan lytic enzyme.Some Gram-negative bacteria as dust Xi Shi intestinal bacteria, salmonella typhi, also can be subjected to the destruction of N,O-Diacetylmuramidase.The acellular wall construction of humans and animals cell does not also have peptidoglycan, so N,O-Diacetylmuramidase is to the human body cell free of toxic effects.N,O-Diacetylmuramidase is a kind of small molecular basic protein that extensively is present in nature animal, plant and the microorganism, plays non-special defense mechanism in body.The anti-microbial effect that is used for N,O-Diacetylmuramidase just still medically all has important use in industry and is worth.At first N,O-Diacetylmuramidase is pharmaceutically acceptable, and tool is antibiotic, remove effects such as local necrosis tissue, hemostasis, detumescence, anti-inflammatory and recovery organization function, medically can be used to make antiphlogistic drug etc.In foodstuffs industry, can be used as sanitas, also can be added in the toothpaste as preventing and treating the medicinal toothpaste of carious tooth.Be a kind of important bacteriolysant on fermentation industry, be used to deposit and make cell walls, prepare no thalline extracting solution.
N,O-Diacetylmuramidase can be divided into four types: c type (hen egg-white lysozyme, chicken egg-white lysozyme, cly), the g type (the goose hen egg white lysozyme, goose egg-white lysozyme, gly), i type (invertebratelysozyme), phage lysozyme.Most of N,O-Diacetylmuramidase all belongs to the c type, and cly is made up of 130 amino-acid residues, and relative molecular mass is 14700.Gly finds that by Jolles and Canfield contain 185 amino-acid residues approximately, relative molecular mass is 21000 the earliest.Olsen, the shellfish i type N,O-Diacetylmuramidase and the c type N,O-Diacetylmuramidase of reports such as Nilson have certain homology.Phage lysozyme is positioned at various phages, and dissolving host bacterium is played an important role, and it contains 164 amino-acid residues, and relative molecular mass is 18700.The report that in invertebrates, does not also have at present the g-N,O-Diacetylmuramidase, the carp g-lysozyme that the Savan report is arranged of relevant marine organisms report, the white shrimp c-lysozyme of Rogerio report, the zebra fish c-lysozyme of FengLiu report, the lefteye flounder g-lysozyme of Hikima report, and Olsen, the shellfish i-lysozyme that has homology with cly of reports such as Nilson.
N,O-Diacetylmuramidase is resisted at seashells and is played the part of important role in the pathogenic bacterial infection, and because its this exclusive low temperature, high salt action environment can make it to be different from existing Mammals N,O-Diacetylmuramidase, have important application prospects, it can be applicable to different field such as marine organisms medicine, marine organisms immunity, aquatic product low temperature storage and transport.
Summary of the invention
The present invention utilizes construction cDNA library, EST analysis, 3 ' and 5 ' RACE technology, chlamys farreri G type lysozyme gene is studied, from chlamys farreri, be cloned into G type lysozyme gene first, this gene can be used for the in-vitro recombination expression and the transgenosis of lysozyme gene, for the exploitation of pharmaceutical prod exploitation, the research of scallop immunology, hereditary and selection and improvement, disease control and fresh-keeping product and sanitas is laid a good foundation.
G type lysozyme gene is cloned in the present invention from chlamys farreri, it has the base sequence shown in the SEQ ID NO.1; Its proteins encoded has the aminoacid sequence shown in the SEQ ID NO.2.
The method of being cloned into G type lysozyme gene from chlamys farreri comprises:
(1) purifying of the extraction of the total RNA of chlamys farreri and mRNA;
(2) chlamys farreri cDNA library construction;
(3) the extensive mensuration of chlamys farreri cDNA library est sequence;
(4) homology analysis of chlamys farreri est sequence and the segmental screening of chlamys farreri G type lysozyme gene;
(5) carry out 3 ' and 5 ' RACE with gene-specific primer CFLyzF 5 '-CATCCGCTACCACTCCTGTC-3 ' and CFLyzR 5 '-CAACTACGTCATTGCTGTAGTC-3 ' and be cloned into chlamys farreri G type lysozyme gene cDNA full length sequence.
The extraction of the total RNA of described chlamys farreri is to extract total RNA from the chlamys farreri hemolymph that has infected Vibrio anguillarum.
The chlamys farreri G type lysozyme gene that the present invention clone obtains, this gene cDNA total length 829bp has the open reading frame of a 600bp, 200 amino acid of encoding, the long 21bp of 5 ' non-coding region, the long 208bp of 3 ' non-coding region has polyadenylic acid tailing signal and polyadenylic acid tail; This gene has critical function aspect the scallop immune defense.
The present invention utilizes expressed sequence tag (EST) technology, cDNA 3 ' and 5 ' rapid amplifying technology (RACE) to be cloned into G type lysozyme gene from chlamys farreri, can be used for the recombinant expressed and transgenosis of N,O-Diacetylmuramidase, and for the disease control of chlamys farreri, gene assist-breeding and further be developed as pharmaceutical prod and lay the foundation.The sequence of prepared chlamys farreri G type lysozyme gene can be in the application in the chlamys farreri hereditary and selection; Also can be in the expression in bacterium, yeast and the insect cell line; Its recombination expression product also can be in the application in drug manufacture, fodder additives and sanitas and the preservation agent production simultaneously.
Embodiment
The chlamys farreri G type lysozyme gene that 1. 1 kinds of clones of embodiment obtain has following sequence:
(1) information of SEQ ID NO.1 in the sequence table
Sequence signature
Length: 829 base pairs
Type: nucleic acid
Chain: two strands
Topological framework: linear
Source: chlamys farreri (Chlamys farreri)
Sequence description:
GCACGAGGCTAGATTCCAACGATGAACCCACTGGCAGTACTCACACTTCTTGCTATCAGCACTG
GTGCCTGGGCAGCGTCCTACACCTGCCATGGTGACGTCACACGACTTCATCCCCATGGACAACA
CAATAGAGGTGTCGCTGCATCCAACCGTGGCGTAGATTACGATTACCATGACCTGTTAGCCAAG
AAAAGTTGTTACGAAGCATCAGGCGCACGACACTGTATTCAGCCGTCTGTGATTGCCGCCTTGG
CCAGTCGAGAATCACGTGGAGGGCGTCTTCTGACGTCAACAGGAGGATGGGGAGATCATCACCA
TGCCTACGGTATATTACAGTGTGACATCCGCTACCACTCCTGTCAGCAGTACGCTTGGAACAGT
TGTGAACACATAGAACAAATGGTGAAGGAGGTCCTTGTGGCATACATCGGTCAGGTGGCGCGTA
AACATCCCACGTGGTCACGAGATCAGCAACTCCAAGGTGGTATCGCCGCCTACAACTCCGGAGT
TGGCAACGTCCAGACCTGGGCCCACCTCGACGTCGGCACAACCGGAAATGACTACAGCAATGAC
GTAGTTGCGCGTGCTAAACACCTTATTTCAAGCCACGGCTGGCATTAAATGCGATTAAGCACGA
AAGAGAGCCACCCATGCTAATTTCAAGATATAATATTCAAAAGAGCGATATTTTTACTTTGAAG
AGATAATCGTTTTAAGGACAGGACATAGAAATCATGCATTGTTGGTAATGGCTTGCATATTACA
GTAATAAACGGTTGTACTAATGTTCTTCAAAACCAAAAAAAAAAAAAAAAAAAAAAAAAAA
(2) information of sequence table SEQ ID NO.2
Sequence signature:
Length: 200 amino acid
Type: amino acid
Chain: strand
Topological framework: linear
Source: chlamys farreri (Chlamys farreri)
Sequence description:
MNPLAVLTLLAISTGAWAASYTCHGDVTRLHPHGQHNRGVAASNRGVDYDYHDLLAKKSCYEAS
GARHCIQPSVIAALASRESRGGRLLTSTGGWGDHHHAYGILQCDIRYHSCQQYAWNSCEHIEQM
VKEVLVAYIGQVARKHPTWSRDQQLQGGIAAYNSGVGNVQTWAHLDVGTTGNDYSNDVVARAKH
LISSHGWH
The clone of embodiment 2. chlamys farreri G type lysozyme genes
1) purifying of the extraction of the total RNA of chlamys farreri and mRNA: from the closed shell flesh of the chlamys farreri that infected Vibrio anguillarum, gather hemolymph with syringe, centrifugal 10 minutes of 4 ℃ of 700g, utilize the Trizol reagent of Invitrogen company and extract total RNA, utilize the Oligotex mRNA purification kit purified mRNA of QIAGENE company with reference to its explanation.
2) chlamys farreri cDNA library construction: utilize cDNA Synthesis Kit of Stratagene company and ZAP-cDNA  Synthesis Kit (Stratagene) and consult and use explanation and carry out the synthetic of cDNA, double-stranded cDNA is through end-filling, EcoR I joint connects, EcoR I terminal phosphateization, utilize the QIAEX II Agarose Gel Extraction Kit of QIAGEN company that the endonuclease bamhi greater than 100bp is reclaimed behind the Xho I endonuclease digestion, be connected with Invetrogen company Uni-ZAP XR vector carrier, utilize the ZAP-cDNA  Gigapack  III Gold Cloning Kit test kit of Stratagene company to carry out the library packing, utilize Exassist Helper Phage and SOLR bacterial strain from Uni-ZAP Cut pBluescript outside the XR Vector upper body and become plasmid library.
3) the extensive mensuration of chlamys farreri cDNA library est sequence: screening positive clone from the library, use carrier universal primer T3 on the MegaBACE1000 sequenator, to carry out sequencing, with parent mass peak map file (the * .abi that obtains, * .abd file) data are converted into sequential file (* .seq) and quality document (* .seq.qual) through the Phred routine processes, the numerical value that provides according to quality document determines to obtain the word error probability of sequence, remove low-quality base, with the carrier sequence in the cross-mach program mask data, from the data that obtain, choose continuous base quality greater than Q13 (accuracy rate is greater than 95%) and length greater than the sequence of 100bp as the EST data.
4) homology analysis of chlamys farreri est sequence and the segmental screening of chlamys farreri G type lysozyme gene: whole effectively EST data that will obtain are carried out the cluster splicing, generate Contigs and Singletons, respectively Contigs and the Singletons that is obtained carried out BLASTn and BLASTx analysis in database, seek out and G type lysozyme gene homologous est sequence according to the similarity analysis result.
5) clone of chlamys farreri G type lysozyme gene cDNA full length sequence: utilize 3 ' and 5 ' RACE technology clone chlamys farreri G type lysozyme gene cDNA full length sequence, according to designing gene-specific primer CFLyzF 5 '-CATCCGCTACCACTCCTGTC-3 ' and CFLyzR 5 '-CAACTACGTCATTGCTGTAGTC-3 ' with G type lysozyme gene homologous est sequence, utilize carrier universal primer T3 respectively, T7 and CFLyzF, CFLyzR carries out 3 ' and 5 ' terminal amplification, the PCR product detects with 1.5% agarose electrophoresis, reclaim recovery and the purifying that test kit (go up marine Ke Kairui Biochip company) carries out the PCR product with glue, be connected with pMD-18T carrier (the precious biotechnology in Dalian company limited) again, transform the XL1-blue bacterial strain, select positive colony and extract plasmid, carry out PCR with CFLyzF and CFLyzR primer and carrier primer and detect, carry out sequencing after confirming to insert clip size.The sequence that records obtains full length sequence after CLUSTER analyzes splicing;
3 ' end used system of pcr amplification and reaction conditions: 25 μ l reaction systems: 2.5 μ l, 10 * PCRbuffer, 1.0 μ l MgCl 2(2.5mM), 2.0 μ l dNTP (2.5mM), 1 μ l primer CFLyzF (10pmol/ μ l), 1 μ l primer T7 (10pmol/ μ l), 16.3 μ l of PCR-grade water, 0.2 μ l (1U) Taq polymerase (Promega), 1 μ l cDNA template.
Be reflected among the PTC-100 Programmable Thermal Controller Cycler (MJ Research) and carry out, reaction conditions is: at first 94 ℃ of pre-sex change are 5 minutes, enter following circulation then: 94 ℃ of sex change 30 seconds, annealed 30 seconds for 59 ℃, 72 ℃ were extended 55 seconds, carry out 31 circulations altogether, last 72 ℃ were extended 10 minutes.
5 ' end used system of pcr amplification and reaction conditions: 25 μ l reaction systems: 2.5 μ l, 10 * PCRbuffer, 1.0 μ l MgCl 2(2.5mM), 2.0 μ l dNTP (2.5mM), 1 μ l primer CFLyzR (10pmol/ μ l), 1 μ l primer T3 (10pmol/ μ l), 16.3 μ l of PCR-grade water, 0.2 μ l (1U) Taq polymerase (Promega), 1 μ l cDNA template.
Be reflected among the PTC-100 Programmable Thermal Controller Cycler (MJ Research) and carry out, reaction conditions is: at first 94 ℃ of pre-sex change are 5 minutes, enter following circulation then: 94 ℃ of sex change 30 seconds, annealed 30 seconds for 57 ℃, 72 ℃ were extended 55 seconds, carry out 34 circulations altogether, last 72 ℃ were extended 10 minutes.
The application of sequence in the chlamys farreri hereditary and selection of embodiment 3. chlamys farreri G type lysozyme genes
Sequences Design PCR and RT-PCR primer according to SEQ ID NO.1 in the sequence table among the embodiment 1, partial sequence to chlamys farreri Different Individual G type lysozyme gene increases and sequencing, compare the difference of Different Individual on G type lysozyme gene sequence, compare the difference of Different Individual G type lysozyme gene mRNA expression level simultaneously, instruct the hereditary and selection of chlamys farreri with this.
The application of the recombinant expressed and recombination expression product of embodiment 4. chlamys farreri G type lysozyme genes
According to the corresponding cDNA sequences Design of chlamys farreri G type N,O-Diacetylmuramidase among sequence table SEQ ID NO.2 primer, introduce two different restriction enzyme mutational sites, be cloned into pQE series then, pET series, pGEX-4T series, pPIC series, serial expression vector such as pGAPZ, again with the recombinant expression vector transformed into escherichia coli and the yeast that are built into, screening positive clone and with IPTG or methanol induction Recombinant Protein Expression.Utilize affinity chromatography that expression product is carried out multistage purifying, obtain the reorganization chlamys farreri G type N,O-Diacetylmuramidase of vivoexpression.This product can be used as medicine, fodder additives, sanitas and preservation agent and uses.
Chlamys farreri
SEQUENCE LISTING
<110〉Institute of Oceanology of the Chinese Academy of Sciences
<120〉chlamys farreri G type lysozyme gene and proteins encoded and cloning process thereof
<130>
<160>2
<170>PatentIn version 3.1
<210>1
<211>829
<212>DNA
<213〉chlamys farreri (Chlamys farreri)
<220>
<221>CDS
<222>(22)..(621)
<223>
<400>1
gcacgaggct agattccaac g atg aac cca ctg gca gta ctc aca ctt ctt 51
Met Asn Pro Leu Ala Val Leu Thr Leu Leu
1 5 10
gct atc agc act ggt gcc tgg gca gcg tcc tac acc tgc cat ggt gac 99
Ala Ile Ser Thr Gly Ala Trp Ala Ala Ser Tyr Thr Cys His Gly Asp
15 20 25
gtc aca cga ctt cat ccc cat gga caa cac aat aga ggt gtc gct gca 147
Val Thr Arg Leu His Pro His Gly Gln His Asn Arg Gly Val Ala Ala
30 35 40
tcc aac cgt ggc gta gat tac gat tac cat gac ctg tta gcc aag aaa 195
Ser Asn Arg Gly Val Asp Tyr Asp Tyr His Asp Leu Leu Ala Lys Lys
45 50 55
agt tgt tac gaa gca tca ggc gca cga cac tgt att cag ccg tct gtg 243
Ser Cys Tyr Glu Ala Ser Gly Ala Arg His Cys Ile Gln Pro Ser Val
60 65 70
Chlamys farreri
att gcc gcc ttg gcc agt cga gaa tca cgt gga ggg cgt ctt ctg acg 291
Ile Ala Ala Leu Ala Ser Arg Glu Ser Arg Gly Gly Arg Leu Leu Thr
75 80 85 90
tca aca gga gga tgg gga gat cat cac cat gcc tac ggt ata tta cag 339
Ser Thr Gly Gly Trp Gly Asp His His His Ala Tyr Gly Ile Leu Gln
95 100 105
tgt gac atc cgc tac cac tcc tgt cag cag tac gct tgg aac agt tgt 387
Cys Asp Ile Arg Tyr His Ser Cys Gln Gln Tyr Ala Trp Asn Ser Cys
110 115 120
gaa cac ata gaa caa atg gtg aag gag gtc ctt gtg gca tac atc ggt 435
Glu His Ile Glu Gln Met Val Lys Glu Val Leu Val Ala Tyr Ile Gly
125 130 135
cag gtg gcg cgt aaa cat ccc acg tgg tca cga gat cag cga ctc caa 483
Gln Val Ala Arg Lys His Pro Thr Trp Ser Arg Asp Gln Gln Leu Gln
140 145 150
ggt ggt atc gcc gcc tac aac tcc gga gtt ggc aac gtc cag acc tgg 531
Gly Gly Ile Ala Ala Tyr Asn Ser Gly Val Gly Asn Val Gln Thr Trp
155 160 165 170
gcc cac ctc gac gtc ggc aca acc gga aat gac tac agc aat gac gta 579
Ala His Leu Asp Val Gly Thr Thr Gly Asn Asp Tyr Ser Asn Asp Val
175 180 185
gtt gcg cgt gct aaa cac ctt att tca agc cac ggc tgg cat 621
Val Ala Arg Ala Lys His Leu Ile Ser Ser His Gly Trp His
190 195 200
taaatgcgat taagcacgaa agagagccac ccatgctaat ttcaagatat aatattcaaa 681
agagcgatat ttttactttg aagagataat cgttttaagg acaggacata gaaatcatgc 741
attgttggta atggcttgca tattacagta ataaacggtt gtactaatgt tcttcaaaac 801
caaaaaaaaa aaaaaaaaaa aaaaaaaa 829
<210>2
<211>200
<212>PRT
<213〉chlamys farreri (Chlamys farreri)
<400>2
Met Ash Pro Leu Ala Val Leu Thr Leu Leu Ala Ile Ser Thr Gly Ala
1 5 10 15
Trp Ala Ala Ser Tyr Thr Cys His Gly Asp Val Thr Arg Leu His Pro
20 25 30
His Gly Gln His Asn Arg Gly Val Ala Ala Ser Asn Arg Gly Val Asp
35 40 45
Chlamys farreri
Tyr Asp Tyr His Asp Leu Leu Ala Lys Lys Ser Cys Tyr Glu Ala Ser
50 55 60
Gly Ala Arg His Cys Ile Gln Pro Ser Val Ile Ala Ala Leu Ala Ser
65 70 75 80
Arg Glu Ser Arg Gly Gly Arg Leu Leu Thr Ser Thr Gly Gly Trp Gly
85 90 95
Asp His His His Ala Tyr Gly Ile Leu Gln Cys Asp Ile Arg Tyr His
100 105 110
Ser Cys Gln Gln Tyr Ala Trp Asn Ser Cys Glu His Ile Glu Gln Met
115 120 125
Val Lys Glu Val Leu Val Ala Tyr Ile Gly Gln Val Ala Arg Lys His
130 135 140
Pro Thr Trp Ser Arg Asp Gln Gln Leu Gln Gly Gly Ile Ala Ala Tyr
145 150 155 160
Asn Ser Gly Val Gly Asn Val Gln Thr Trp Ala His Leu Asp Val Gly
165 170 175
Thr Thr Gly Asn Asp Tyr Ser Asn Asp Val Val Ala Arg Ala Lys His
180 185 190
Leu Ile Ser Ser His Gly Trp His
195 200

Claims (4)

1. chlamys farreri G type lysozyme gene is characterized in that: have the base sequence shown in the SEQ ID NO.1.
2. the described chlamys farreri G of claim 1 a type lysozyme gene proteins encoded is characterized in that: have the aminoacid sequence shown in the SEQ ID NO.2.
3. the cloning process of the described chlamys farreri G of claim 1 a type lysozyme gene is characterized in that, comprising:
(1) purifying of the extraction of the total RNA of chlamys farreri and mRNA;
(2) chlamys farreri cDNA library construction;
(3) the extensive mensuration of chlamys farreri cDNA library est sequence;
(4) homology analysis of chlamys farreri est sequence and the segmental screening of chlamys farreri G type lysozyme gene;
(5) utilize 3 ' with 5 ' RACE technology clone chlamys farreri G type lysozyme gene cDNA full length sequence.
4. according to the cloning process of the described chlamys farreri G of claim 3 type lysozyme gene, it is characterized in that the extraction of the total RNA of described chlamys farreri is to extract total RNA from the chlamys farreri hemolymph that has infected Vibrio anguillarum.
CNB2004100506518A 2004-10-22 2004-10-22 G-type lysozyme gene of Chlamys farreri and encoded protein and cloning method thereof Expired - Fee Related CN100344762C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100506518A CN100344762C (en) 2004-10-22 2004-10-22 G-type lysozyme gene of Chlamys farreri and encoded protein and cloning method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100506518A CN100344762C (en) 2004-10-22 2004-10-22 G-type lysozyme gene of Chlamys farreri and encoded protein and cloning method thereof

Publications (2)

Publication Number Publication Date
CN1763201A true CN1763201A (en) 2006-04-26
CN100344762C CN100344762C (en) 2007-10-24

Family

ID=36747520

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100506518A Expired - Fee Related CN100344762C (en) 2004-10-22 2004-10-22 G-type lysozyme gene of Chlamys farreri and encoded protein and cloning method thereof

Country Status (1)

Country Link
CN (1) CN100344762C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103160526A (en) * 2011-12-15 2013-06-19 中国科学院烟台海岸带研究所 Mytilus edulis G-type lysozyme gene and recombinant protein and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083700A (en) * 1998-06-26 2000-07-04 Incyte Pharmaceuticals, Inc. Human goose-type lysozyme
CN1252257C (en) * 2001-03-02 2006-04-19 复旦大学 Human G-type lysozyme and its coding sequence, preparing process and application

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103160526A (en) * 2011-12-15 2013-06-19 中国科学院烟台海岸带研究所 Mytilus edulis G-type lysozyme gene and recombinant protein and application thereof
CN103160526B (en) * 2011-12-15 2014-05-14 中国科学院烟台海岸带研究所 Mytilus edulis G-type lysozyme gene and recombinant protein and application thereof

Also Published As

Publication number Publication date
CN100344762C (en) 2007-10-24

Similar Documents

Publication Publication Date Title
CN1060871A (en) A kind of new cancer tire gene and gene product and purposes
Zhang et al. Molecular characterization and expression analysis of lipopolysaccharide and β-1, 3-glucan-binding protein (LGBP) from pearl oyster Pinctada fucata
CN101063104A (en) Engineering bacterium producing 5-glycyl ethylformic acid and construction method thereof
CN1766109A (en) Chinese prawn C-type agglutinin gene and its coded C-type agglutinin peptide and uses
CN100344763C (en) G-type lysozyme gene of Argopecten irradians and encoded protein and cloning method thereof
CN100344762C (en) G-type lysozyme gene of Chlamys farreri and encoded protein and cloning method thereof
CN100344758C (en) Antibacterial peptide gene of Chinese prawn containing single whey acidic protein structure domain and its coded antibacterial peptide and application
CN1238378C (en) An antibiotic peptide and its coded sequence and use
CN1205335C (en) Tumor death induction ligand gene, gene expression protein and its preparation method
CN1740320A (en) Fenneropenaeus chinensis Anti-LPS factor gene and cloning process thereof
CN1831109A (en) Recombinant bacteria of coding macrotherm phytase gene, synthesis, cloning and expression of said gene
CN1752210A (en) Chicken interferon gamma, preparing process and use thereof
CN1800398A (en) Prunus necrotic ring spot virus coat protein gene and its special primer for checking
CN1236059C (en) Grouper insulin-like growth factor II gene, carrier and recombinant strain containing the gene and application thereof
CN1821271A (en) Antibiotic peptide and its code sequence and use
CN1763092A (en) Antibiotic peptide and its coding sequence and uses
CN1624127A (en) Hepcidin antibacterial peptide gene of genuine porgy cultured in sea water
CN1632120A (en) Hepcidin antibiotic peptide gene of weever cultured in sea water
CN1522760A (en) Bivalent gene engineering vaccine of fowl infectious bursal disease and pasteurellosis
CN1772896A (en) Bay scallop phylaxin gene and its coded protein and cloning method
CN101063132A (en) Lateolabrax interleukins 8 gene order
CN1309824C (en) Antibiotic peptide gene converted viscons bacillus engineering bacterium and its preparing method and use
CN1837368A (en) Gene recombine plasmid of pralichthys olivaceus &#39;whole fish&#39; lysozyme
Jolodar Characterization and phylogenetic analysisof a g-type lysozyme gene variant from the skin mucus of grass carp (Ctenopharyngodon idella)
CN1228451C (en) Method for screening poly-drug resistance reverse medicine for rumour

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071024

Termination date: 20101022